亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial

医学 溃疡性结肠炎 安慰剂 内科学 粪便细菌疗法 随机对照试验 胃肠病学 移植 拟杆菌 粪便 双盲 生物 细菌 疾病 抗生素 微生物学 病理 替代医学 遗传学 艰难梭菌
作者
Craig Haifer,Sudarshan Paramsothy,Nadeem Omar Kaakoush,Aiasha Saikal,Simon Ghaly,Tao Yang,Laurence Don Wai Luu,Thomas Julius Borody,Rupert Wing Loong Leong
出处
期刊:The Lancet Gastroenterology & Hepatology [Elsevier BV]
卷期号:7 (2): 141-151 被引量:301
标识
DOI:10.1016/s2468-1253(21)00400-3
摘要

Summary

Background

Faecal microbiota transplantation (FMT) delivered via colonoscopic infusion or enemas have been shown to induce remission in a proportion of patients with active ulcerative colitis. Whether orally administered FMT is effective in ulcerative colitis is unknown. We aimed to assess the efficacy of oral lyophilised FMT for the treatment of active ulcerative colitis.

Methods

A double-blind, randomised, placebo-controlled trial was conducted at two centres in Australia. Eligible patients were aged 18–75 years with active ulcerative colitis (defined as clinical and endoscopic active ulcerative colitis, with a total Mayo score of 4–10, and a Mayo endoscopic subscore ≥1). After 2 weeks of amoxicillin, metronidazole, and doxycycline, patients were randomly assigned in a 1:1 ratio to receive either oral lyophilised FMT or placebo capsules for 8 weeks, using a prespecified computer-generated randomisation list with a permuted block size of 8. The primary outcome was corticosteroid-free clinical remission with endoscopic remission or response (total Mayo score ≤2, all subscores ≤1, and ≥1 point reduction in endoscopic subscore) at week 8. At week 8, FMT responders were randomly assigned (in a 1:1 ratio, permuted block size of 8) to either continue or withdraw FMT for a further 48 weeks. Analyses were done by modified intention-to-treat, including all patients who received at least one study dose. This trial is registered with Australian New Zealand Trial Registry, number ACTRN 12619000611123; this is the final report of the trial.

Findings

Between May 20, 2019, and March 24, 2020, 35 patients were randomly assigned: 15 to receive FMT and 20 to receive placebo. Recruitment was terminated early due to the COVID-19 pandemic. At week 8, eight (53%) of 15 patients in the FMT group were in corticosteroid-free clinical remission with endoscopic remission or response, as were three (15%) of 20 patients in the placebo group (difference 38·3%, 95% CI 8·6–68·0; p=0·027; odds ratio 5·0, 95% CI 1·8–14·1). Adverse events occurred in 10 (67%) patients in the FMT group and 17 (85%) of those in the placebo group during the 8-week induction period, and were generally mild and self-limiting gastrointestinal complaints. Serious adverse events included worsening ulcerative colitis (two in the FMT group, one in the placebo group) and per-rectal bleeding (one in the placebo group). Ten patients in the FMT group who achieved a clinical or endoscopic response entered the maintenance phase and were randomly assigned to continue open-label FMT (n=4) or withdraw therapy (n=6). All four (100%) patients who continued FMT were in clinical, endoscopic, and histologic remission at week 56 compared with none of the patients who had FMT withdrawn.

Interpretation

Antibiotics followed by orally administered FMT was associated with the induction of remission in patients with active ulcerative colitis. Continuing FMT was well tolerated and appeared to demonstrate clinical, endoscopic, and histological efficacy. Oral FMT could be a promising and feasible treatment option for patients with ulcerative colitis.

Funding

St Vincent's Clinic Foundation, Gastroenterological Society of Australia, Gutsy Group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
乐乐的应助被邓润杰采纳,获得20
1秒前
充电宝的应助被儒雅傲人采纳,获得10
1秒前
Dd关闭了Dd的文献求助
1秒前
3秒前
瘦瘦不乐完成签到,获得积分10
5秒前
lim完成签到,获得积分10
5秒前
漂亮的元灵完成签到,获得积分10
7秒前
8秒前
月亮完成签到 ,获得积分10
9秒前
9秒前
儒雅傲人发布了新的文献求助10
14秒前
Dd完成签到,获得积分10
14秒前
王春梅完成签到 ,获得积分10
16秒前
唠叨的乌完成签到 ,获得积分20
21秒前
赘婿的应助被科研通管家采纳,获得10
25秒前
MchemG的应助被科研通管家采纳,获得30
25秒前
华仔的应助被科研通管家采纳,获得200
25秒前
Nina完成签到,获得积分10
31秒前
sshh123完成签到,获得积分10
31秒前
xiajinjin完成签到,获得积分20
36秒前
糟糕的访波完成签到,获得积分10
40秒前
酷波er的应助被风趣含双采纳,获得10
41秒前
41秒前
手拿把掐发布了新的文献求助30
46秒前
陌陌完成签到 ,获得积分10
48秒前
52秒前
53秒前
煊陌完成签到 ,获得积分10
53秒前
伶俐鞋子完成签到,获得积分10
54秒前
科研通AI6.4的应助被儒雅傲人采纳,获得10
57秒前
风趣含双发布了新的文献求助10
57秒前
1分钟前
1分钟前
科研通AI6.3的应助被CMJ采纳,获得10
1分钟前
可乐发布了新的文献求助10
1分钟前
PaakLaam完成签到,获得积分10
1分钟前
1分钟前
Asdaf完成签到,获得积分10
1分钟前
万能图书馆的应助被灵剑山采纳,获得10
1分钟前
SODAPIE完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172954
求助须知:如何正确求助?哪些是违规求助? 9565479
关于积分的说明 21780097
捐赠科研通 7764853
什么是DOI,文献DOI怎么找? 3431513
关于科研通互助平台的介绍 2555530
邀请新用户注册赠送积分活动 2476595